FDA-Approved Antidepressant May Combat Deadly Form of Lung Cancer, Study Finds

FDA-approved antidepressant may combat deadly form of lung cancer, study finds
The drug maintained its effectiveness regardless of whether the cancer cells had previously been exposed, and become resistant, to traditional chemotherapy treatments. Another drug, an antihistamine called promethazine, identified by the bioinformatics … Read more on Toronto NewsFIX

Clinical Site Services – Sheppard Pratt – Treatment-resistant Depression – Clinical Site Services – Sheppard Pratt – Treatment-resistant Depression.